Blog: Nestle receives green light on Pfizer deal

Michelle Russell | 6 November 2012

Swiss food group Nestle today (6 November) received approval from the Chinese Ministry of Commerce for its US$11.85bn deal to acquire Pfizer's infant nutrition business.

The approval brings Nestle another step closer to completing the acquisition, which was announced in April this year, enabling the world's largest infant nutrition group to extend its lead in this fast-growing category.

Pfizer Nutrition operates in more than 60 countries globally and 85% of sales are generated in emerging markets, meaning the acquisition effectively fills in the blanks on the map for Nestle. It will provide the company with increased scale in a high-growth, high-margin, category in fast-growing developing markets, CEO Paul Bulcke told investors as it emerged as victor of competitive auction process.

Nestle beat companies including Danone and Mead Johnson to seal the agreement. The next hurdle, however, is to receive approval from anti-trust bodies in several countries in order to fully complete the acquisition.


BLOG

Bar brawl - US snack firms Clif and Kind joust over ingredients

Clif Bar & Co. and US snack peer Kind have become involved in a public spat over the ingredients the companies use in their snack bars....

BLOG

Amazon pulls plug on Dash buttons

The retail behemoth has said shoppers will no longer be able to buy its Dash buttons, which had allowed consumers to re-order products with one push of a finger....

BLOG

Ex-PepsiCo chief Indra Nooyi gets seat on Amazon board

Former PepsiCo CEO Indra Nooyi has secured a high-profile directorship, with retail giant Amazon appointing the CPG veteran to its board of directors....



Forgot your password?